Explore the key differences between Spravato and IV Ketamine, including FDA approval, administration, eligibility, and how to determine which treatment may be appropriate for you.
Living with depression can be challenging, especially when symptoms continue despite trying standard treatment approaches. For some adults with treatment-resistant depression (TRD), advanced therapies such as Spravato® (esketamine) and IV Ketamine may be considered as part of a comprehensive treatment plan.
Although these treatments are related, they are not the same. Understanding how they differ can help you have a more informed conversation with your healthcare provider about the options that best align with your medical history and treatment goals.
Spravato® is an FDA-approved prescription nasal spray that contains esketamine, a derivative of ketamine. It is approved for adults with treatment-resistant depression (TRD) and certain adults with major depressive disorder (MDD) experiencing acute suicidal thoughts or behaviors when used as part of a comprehensive treatment plan and in accordance with its approved indications.
Because Spravato can cause temporary side effects such as sedation and dissociation, it is administered only in certified healthcare settings under the supervision of trained medical professionals. Patients are monitored after each treatment session before returning home.
IV Ketamine therapy delivers ketamine directly into the bloodstream through an intravenous (IV) infusion. Ketamine has been used safely as an anesthetic for decades. However, its use in treating depression is considered off-label, meaning it has not received FDA approval specifically for depression treatment.
Some healthcare providers may recommend IV Ketamine for certain patients after carefully evaluating their medical history and treatment needs. As with any medical treatment, potential benefits and risks should be discussed with a qualified healthcare provider.
Although both treatments involve compounds related to ketamine, they differ in several important ways.
| Feature | Spravato® | IV Ketamine |
|---|---|---|
| FDA Status | FDA-approved for specific depression indications | Used off-label for depression |
| Active Medication | Esketamine | Ketamine |
| Administration | Nasal spray | Intravenous infusion |
| Treatment Setting | Certified healthcare facility | Medical clinic or infusion center |
| Monitoring | Required after each treatment | Required during and after infusion |
Your provider will consider these differences, along with your diagnosis, medical history, and treatment goals, when discussing potential treatment options.
Choosing between Spravato and IV Ketamine is a decision that should always be made with your healthcare provider. Factors that may influence treatment recommendations include:
Because every patient’s experience is unique, a personalized evaluation is the best way to determine the most appropriate treatment approach.
At Pinnacle Behavioral Healthcare, we believe depression treatment should be personalized, evidence-informed, and focused on your individual needs. Our experienced behavioral health providers carefully evaluate each patient’s symptoms, treatment history, and overall health before recommending appropriate care.
If advanced depression treatment is appropriate, we’ll explain your options, answer your questions, and develop a treatment plan designed to support your long-term mental wellness.
No. Spravato contains esketamine, which is a form of ketamine, but it is a different medication with specific FDA-approved indications and administration requirements.
A comprehensive psychiatric evaluation is the best way to determine whether advanced depression treatment may be appropriate. Your provider will review your symptoms, treatment history, medical conditions, and individual goals before making recommendations.
If you’ve been living with depression that hasn’t responded to traditional treatment, you don’t have to navigate your options alone. Our compassionate team is here to help you better understand advanced treatment approaches and determine whether Spravato may be an appropriate part of your care plan.
Contact Pinnacle Behavioral Healthcare today to schedule a confidential consultation and learn more about personalized depression treatment options available in Edina, Minneapolis, and surrounding Minnesota communities.
